Back to results
CompletedPhase 3

Glutamate for Metabolic Intervention in Coronary Surgery II

NCT02592824

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Sahlgrenska University Hospital

Gothenburg, Sweden

+3 additional locations

View on ClinicalTrials.gov
Glutamate for Metabolic Intervention in Coronary Surgery II — TrialFind